CN103570520A - Benzoquinones compound, preparation method and application thereof - Google Patents

Benzoquinones compound, preparation method and application thereof Download PDF

Info

Publication number
CN103570520A
CN103570520A CN201310366156.7A CN201310366156A CN103570520A CN 103570520 A CN103570520 A CN 103570520A CN 201310366156 A CN201310366156 A CN 201310366156A CN 103570520 A CN103570520 A CN 103570520A
Authority
CN
China
Prior art keywords
formula
compound
chloro
phenyl
cyclohexyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310366156.7A
Other languages
Chinese (zh)
Other versions
CN103570520B (en
Inventor
董咪咪
颜丙春
郭强
董坤
彭欣
武茂成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG LUKANG SHELILE PHARMACEUTICAL CO Ltd
Original Assignee
SHANDONG LUKANG SHELILE PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG LUKANG SHELILE PHARMACEUTICAL CO Ltd filed Critical SHANDONG LUKANG SHELILE PHARMACEUTICAL CO Ltd
Priority to CN201310366156.7A priority Critical patent/CN103570520B/en
Publication of CN103570520A publication Critical patent/CN103570520A/en
Application granted granted Critical
Publication of CN103570520B publication Critical patent/CN103570520B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/24Quinones containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/16Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by condensation involving hydroxy groups of phenols or alcohols or the ether or mineral ester group derived therefrom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a benzoquinones compound, a preparation method and application thereof, and belongs to the drug synthesis field. The method comprises the following steps: condensing alpha-naphthol and 4-(4-chlorophenyl)cyclohexanol under acid catalysis to obtain 2-(4-(4-chlorophenyl)cyclohexyl)-1-naphthol (formula IV), oxidizing the compound represented by formula IV to obtain 2-(4-(4-chlorophenyl)cyclohexyl)-1,4-naphthoquinone (formula III), enabling the compound represented by the formula III to react with bromine in additive reaction to obtain 2,3-dibromo-2-(4-(4-chlorophenyl)cyclohexyl)-1,4-naphthoquinone (formula I), releasing a molecule of hydrogen bromide to obtain 3-bromo-2-(4-(4-chlorophenyl)cyclohexyl)-1,4-naphthoquinone (formula II). The method further discloses a method for preparing atovaquone by using the compound, the synthesis method is simple, the AgNO3 can be prevented from using, and the total yield is high.

Description

A kind of benzoquinone compound, its preparation method and application thereof
Technical field
The present invention relates to medicine synthetic field, specifically a kind of benzoquinone compound, its preparation method and application thereof.
Background technology
Quinones is a class at distributed in nature compound widely, and it comprises quinones and easily changes the compound of quinones character into.
From structure, quinones can be divided into benzoquinones, and naphthoquinones and anthraquinone have many-sided physiologically active, as antidiarrheal, antibiotic, diuresis and hemostasis etc., also has some quinoness to have the effects such as anticancer, antiviral, spasmolysis is relievingd asthma.Although disclose the preparation method of some quinoness, particularly benzoquinone compound in prior art, commonly used expensive catalyzer in preparation process, as AgNO 3deng, production cost is higher.
Atovaquone (Atovaquone) is a kind of homologue of ubiquinone, the trouble that is applicable to tolerate SMZ-TMP is slightly to patient's AIDS of moderate Ka Shi pneumonia oral administration, but also it is active to show certain anti-malarial, its chemistry 2-(trans-4-(4-chloro-phenyl-) cyclohexyl) by name-3-hydroxyl-1,4-naphthalenedione, chemical structure is suc as formula shown in (1)
Figure 275601DEST_PATH_IMAGE001
Formula (1)
In prior art, the main synthetic atovaquone of following several method that adopts:
Figure 117042DEST_PATH_IMAGE002
The main reference of this method is US 5053432 and EP 0362996, and the main synthesis technique that above-mentioned technique is current atovaquone is generated by the chloro-1,4-naphthoquinone of 2-(chlorinated naphthoquinone) and the condensation reaction of 4-(4-chloro-phenyl-)-cyclohexyl-1-formic acid.Reaction be take acetonitrile as solvent, under Silver Nitrate exists, uses ammonium persulphate oxidative decarboxylation, generates the chloro-3-of (3S)-2-(4-(4-chloro-phenyl-) cyclohexyl) Isosorbide-5-Nitrae-naphthalenedione.Under alkaline condition, hydrolysis obtains final product (3S)-2-hydroxyl-3-(4-(4-chloro-phenyl-) cyclohexyl) Isosorbide-5-Nitrae-naphthalenedione, i.e. atovaquone.The main drawback of this route is that the solvent that oxidative decarboxylation is used is acetonitrile, acetonitrile is to 2-chloro-1, the solubleness of 4-naphthoquinones (chlorinated naphthoquinone), 4-(4-chloro-phenyl-)-cyclohexyl-1-formic acid and Silver Nitrate has very big-difference, and along with adding of ammonium persulfate solution, noted phase separation phenomena is very obvious.And this reaction side reaction is more, reaction produces a lot of impurity, causes that product yield is on the low side only 20% left and right.
The main referenced patent of this method is WO 2009/122432 A2, above-mentioned technique is with 2,3-dichlone and 4-(4-chloro-phenyl-) cyclohexylenedinitrilotetraacetic acid is starting raw material, under the catalytic condition of Silver Nitrate and ammonium persulphate, there is condensation reaction, then, be hydrolyzed to obtain the finished product under the effect of alkali, the major advantage of this technique is yield ratio method (1) height, condensation reaction yield is up to 40%, and hydrolysis reaction yield reaches 95.5%.But this method has been used AgNO equally 3and ammonium persulphate, production cost is higher, bad to environmental influence.
In above-mentioned two kinds of methods, all used expensive AgNO 3, not only cost is high and productive rate is all very low, and meanwhile, last handling process also can produce very havoc to environment.
Summary of the invention
Technical assignment of the present invention is for above-mentioned the deficiencies in the prior art, and a kind of benzoquinone compound that can be used for producing atovaquone is provided.
Second technical assignment of the present invention is to provide the preparation method of above-mentioned benzoquinone compound.
The 3rd technical assignment of the present invention is to provide the application of above-mentioned benzoquinone compound.
Technical assignment of the present invention is realized in the following manner: have formula the benzoquinone compound of chemical structure, called after: 2,3-dibromo 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
Figure 699836DEST_PATH_IMAGE005
There is formula
Figure 787878DEST_PATH_IMAGE004
the preferred following methods of benzoquinone compound of chemical structure makes: the condensation under acid catalysis of naphthyl alcohol and 4-(4-chloro-phenyl-) hexalin obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV); Compound shown in formula IV, through oxidation, obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula III).Compound shown in formula III and bromine generation addition reaction, obtain the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I).
  
Synthetic route equation is as follows:
Figure 320490DEST_PATH_IMAGE006
Above-mentioned preparation method comprises the following steps:
A, preparation 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV)
By naphthyl alcohol, 4-(4-chloro-phenyl-) hexalin and solvent, under 120 ~ 150 ℃, acid catalyst catalytic condition, react complete to raw material reaction, obtain compound shown in formula IV;
Described naphthyl alcohol and 4-(4-chloro-phenyl-) hexalin mol ratio is 1:1 ~ 4;
The mol ratio of described acid catalyst and two raw materials (naphthyl alcohol, 4-(4-chloro-phenyl-) hexalin) sum is 0.1 ~ 1:1;
B, prepare the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I)
Under acid catalysis, with compound shown in oxygenant oxidation-type IV, obtain compound shown in formula III; Bromine simple substance reacts and obtains compound shown in formula I with compound shown in formula III.
Further:
In steps A, described solvent is preferably benzene, toluene or chlorobenzene; Described acid catalyst is preferably toluenesulphonic acids, trifluoroacetic acid, acetic acid, the vitriol oil or phosphoric acid.
Step B can complete in two steps, also can one completes, and all can reach good effect.
While completing in two steps, its detailed process is respectively:
A, compound shown in steps A gained formula IV is added in solvent, under appropriate amount of acid catalyst action, with oxygenant oxidation, after completion of the reaction, obtain compound shown in formula III;
Described solvent is preferably acetone, acetonitrile or tetrahydrofuran (THF);
Shown in described acid catalyst and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described oxygenant and formula IV, the mol ratio of compound is 1 ~ 20:1;
The temperature of reaction of described oxidizing reaction is 60 ~ 90 ℃;
B, a certain amount of bromine simple substance is added shown in the formula III being dissolved in solvent in compound, react complete to raw material reaction, obtain compound shown in formula I;
Shown in described bromine simple substance and formula III, the mol ratio of compound is 1 ~ 5:1;
Described solvent is preferably tetracol phenixin, dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
When one step completes, its detailed process is:
Compound shown in steps A gained formula IV and appropriate bromine simple substance are added in solvent, and under appropriate amount of acid catalyst action, with oxygenant oxidation, back flow reaction, after completion of the reaction, purifies and obtains compound shown in formula I;
Shown in described bromine simple substance and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described acid catalyst and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described oxygenant and formula IV, the mol ratio of compound is 1 ~ 20:1;
The temperature of reaction of described oxidizing reaction is 60 ~ 120 ℃;
Described solvent is tetracol phenixin, dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
In step B, described oxygenant is preferably hydrogen peroxide, chromic oxide, cerous sulfate, ceric ammonium nitrate, potassium permanganate, Manganse Dioxide or dichromate;
Described acid catalyst is preferably concentrated hydrochloric acid, Glacial acetic acid or the vitriol oil.
The benzoquinone compound with formula II chemical structure, by formula
Figure 519391DEST_PATH_IMAGE004
the hydrogen bromide that the benzoquinone compound of chemical structure is sloughed a part makes.The bromo-2-of called after: 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula II).
Figure 594794DEST_PATH_IMAGE007
Synthetic route equation is as follows:
Figure 853737DEST_PATH_IMAGE008
The preparation method of the benzoquinone compound of formula II chemical structure is:
By formula
Figure 873646DEST_PATH_IMAGE004
the benzoquinone compound of chemical structure is dissolved in solvent, under 60 ~ 90 ℃ of conditions, reacts 2 ~ 24h, is washed to and occurs precipitation, obtains compound shown in formula II;
Described solvent is preferably dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
Or:
By formula the benzoquinone compound of chemical structure is dissolved in solvent, adds appropriate sodium acetate to make catalyzer, and back flow reaction is to reacting completely, the compound shown in formula II of purifying to obtain;
Described solvent is preferably dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile;
Described in described sodium acetate and claim 1, the mol ratio of benzoquinone compound is 1 ~ 10:1.
The benzoquinone compound of above-mentioned formula II chemical structure can be used for preparing atovaquone, preparation method comprises: under the condition existing at alkali, using alcohol as solvent, the benzoquinone compound generation hydrolysis reaction of formula II chemical structure, after having reacted, washing, can obtain 3-hydroxyl-2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone; The mol ratio of the bromo-2-of described alkali and 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone is 1 ~ 20:1.Synthetic route is as follows:
Described alkali is preferably sodium hydroxide, potassium hydroxide, hydrated barta, lithium hydroxide, carbonate or supercarbonate;
Described alcohol is preferably one or more the mixture in methyl alcohol, ethanol, n-propyl alcohol, Virahol, propyl carbinol or isopropylcarbinol.
Benzoquinone compound of the present invention, its preparation method and application thereof compared with prior art have following outstanding beneficial effect:
(1) in benzoquinone compound preparation process, by product is few, and cost is low;
(2), while preparing atovaquone with this compound, can avoid using expensive catalytic reagent AgNO 3, become
This is cheap and do not pollute the environment, can better be for industrial production; Total recovery is higher than existing synthesis technique.
Embodiment
With specific embodiment, benzoquinone compound of the present invention, its preparation method and application thereof are described in detail below.
the embodiment mono-preparation bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone, 3-bromine 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone
The preparation of A, 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV)
Under nitrogen protection; by 4-(4-chloro-phenyl-) hexalin 2.9g, naphthyl alcohol 2g, tosic acid 2.63g adds in 30ml toluene; 140 ℃ of back flow reaction 3h; TLC monitoring reaction is carried out, and after reacting completely, organic phase washes with water; phase-splitting dewaters; organic phase anhydrous sodium sulfate drying, concentrating under reduced pressure, crystallization obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols.
B, 2, the preparation of the bromo-2-of 3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I)
(a), the preparation of 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula III)
Add 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols 2.98g in 15ml acetonitrile, then drip successively 4ml concentrated hydrochloric acid (38%, v/v), 16ml hydrogen peroxide (30%, v/v), stirring reaction 3h at 100 ℃, TLC detection reaction progress, after reacting completely, concentrating under reduced pressure, adds 20ml chloroform, and organic layer washes with water, separate organic layer, condensing crystal, obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
(b), 2, the preparation of the bromo-2-of 3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I)
The bromine simple substance of 60ul is added in the acetic acid of 1ml, the acetic acid solution of bromine is dropped to 2-(4-(4-chloro-phenyl-) cyclohexyl)-1 in 15min, in the mixed system that 4-naphthoquinones 2.24g and acetic acid 5ml form, stirring at room 45min, pours into the reaction solution obtaining in frozen water, has Precipitation, suction filtration, obtain the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
The preparation of the bromo-2-of C, 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula II)
The bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone 5g is dissolved in 25mlDMSO, 60 ℃ of reaction 2h, TLC detection reaction is carried out, after reacting completely, be washed to and occur precipitation, obtain the bromo-2-of 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
embodiment bis-preparation 2,3-dibromo 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinones, 3-bromine 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone
The preparation of A, 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV)
In the there-necked flask of 100ml, add chlorobenzene 30ml, naphthyl alcohol 2g, 4-(4-chloro-phenyl-) hexalin 4.65g and tosic acid 0.8g, back flow reaction 3h, TLC monitors reaction, react complete, concentrating under reduced pressure, adds chloroform extraction, washing, separate organic layer, boil off solvent, obtain product 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols.
B, 2, the preparation of 3-dibromo 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I)
In 30ml tetracol phenixin, add 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols 3.36g, Br 21.6g, 30% superoxol 1.2ml, 98% vitriol oil 0.6ml, reaction solution backflow 20min, concentrate and be cooled to 0 ℃, after suction filtration, retain solid, in filtrate, add suitable quantity of water, by extracted with diethyl ether, concentrate to obtain thick product, the thick product of two portions merges recrystallization and obtains the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
The preparation of the bromo-2-of C, 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula II)
By 2,3-dibromo 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone 0.3g is dissolved in the acetic acid of 10ml, adds the sodium acetate of 0.2g, back flow reaction 1h, TLC monitoring, adds 5ml water in reaction solution, ethyl acetate extraction, anhydrous sodium sulfate drying, concentrating under reduced pressure, obtains the bromo-2-of 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone.
embodiment tri-prepares atovaquone
By the bromo-2-of 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinones 2.145g and sodium hydroxide 1.6g are dissolved in 65ml methyl alcohol, back flow reaction, TLC detection reaction progress, reacts complete, adjust pH2 ~ 3, the concentrated methyl alcohol of removing, with ethyl acetate extraction, vacuum concentration, low temperature crystallization obtains target compound atovaquone (3-hydroxyl-2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone).
embodiment tetra-prepares atovaquone
By the bromo-2-of 3-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinones 2.2g and sodium carbonate 3.18g join in 45ml Virahol, reflux, react complete, filtration under diminished pressure, the concentrated Virahol of removing, with ethyl acetate, extract, vacuum concentration, low temperature crystallization obtains target compound atovaquone (3-hydroxyl-2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone).

Claims (13)

1. there is formula
Figure 2013103661567100001DEST_PATH_IMAGE001
the benzoquinone compound of chemical structure,
Figure 675793DEST_PATH_IMAGE002
2. the preparation method of benzoquinone compound described in claim 1, is characterized in that, the condensation under acid catalysis of naphthyl alcohol and 4-(4-chloro-phenyl-) hexalin obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV); Compound shown in formula IV, through oxidation, obtains 2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula III); Compound shown in formula III and bromine generation addition reaction, obtain the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I).
3. preparation method according to claim 2, is characterized in that comprising the following steps:
A, preparation 2-(4-(4-chloro-phenyl-) cyclohexyl)-1-naphthols (formula IV)
By naphthyl alcohol, 4-(4-chloro-phenyl-) hexalin and solvent, under 120 ~ 150 ℃, acid catalyst catalytic condition, react complete to raw material reaction, obtain compound shown in formula IV;
Described naphthyl alcohol and 4-(4-chloro-phenyl-) hexalin mol ratio is 1:1 ~ 4;
The mol ratio of described acid catalyst and two raw material sums is 0.1 ~ 1:1;
B, prepare the bromo-2-of 2,3-bis-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone (formula I);
Under acid catalysis, with compound shown in oxygenant oxidation-type IV, obtain compound shown in formula III; Bromine simple substance reacts and obtains compound shown in formula I with compound shown in formula III.
4. preparation method according to claim 3, is characterized in that: in steps A,
Described solvent is benzene, toluene or chlorobenzene;
Described acid catalyst is toluenesulphonic acids, trifluoroacetic acid, acetic acid, the vitriol oil or phosphoric acid.
5. preparation method according to claim 3, is characterized in that, the detailed process of step B is:
A, compound shown in steps A gained formula IV is added in solvent, under appropriate amount of acid catalyst action, with oxygenant oxidation, after completion of the reaction, obtain compound shown in formula III;
Described solvent is acetone, acetonitrile or tetrahydrofuran (THF);
Shown in described acid catalyst and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described oxygenant and formula IV, the mol ratio of compound is 1 ~ 20:1;
The temperature of reaction of described oxidizing reaction is 60 ~ 90 ℃;
B, a certain amount of bromine simple substance is added shown in the formula III being dissolved in solvent in compound, react complete to raw material reaction, obtain compound shown in formula I;
Shown in described bromine simple substance and formula III, the mol ratio of compound is 1 ~ 5:1;
Described solvent is tetracol phenixin, dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
6. preparation method according to claim 3, is characterized in that, the detailed process of step B is:
Compound shown in steps A gained formula IV and appropriate bromine simple substance are added in solvent, and under appropriate amount of acid catalyst action, with oxygenant oxidation, back flow reaction, after completion of the reaction, purifies and obtains compound shown in formula I;
Shown in described bromine simple substance and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described acid catalyst and formula IV, the mol ratio of compound is 1 ~ 5:1;
Shown in described oxygenant and formula IV, the mol ratio of compound is 1 ~ 20:1;
The temperature of reaction of described oxidizing reaction is 60 ~ 120 ℃;
Described solvent is tetracol phenixin, dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
7. according to the preparation method described in claim 5 or 6, it is characterized in that:
Described oxygenant is hydrogen peroxide, chromic oxide, cerous sulfate, ceric ammonium nitrate, potassium permanganate, Manganse Dioxide or dichromate;
Described acid catalyst is concentrated hydrochloric acid, Glacial acetic acid or the vitriol oil.
8. the benzoquinone compound with formula II chemical structure,
Figure 2013103661567100001DEST_PATH_IMAGE003
The hydrogen bromide of being sloughed a part by benzoquinone compound described in claim 1 makes.
9. the preparation method of benzoquinone compound described in claim 8, is characterized in that, benzoquinone compound described in claim 1 is dissolved in solvent, under 60 ~ 90 ℃ of conditions, reacts 2 ~ 24h, is washed to and occurs precipitation, obtains compound shown in formula II;
Described solvent is dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile.
10. the preparation method of benzoquinone compound described in claim 8, is characterized in that, benzoquinone compound described in claim 1 is dissolved in solvent, adds appropriate sodium acetate to make catalyzer, and back flow reaction is to reacting completely, the compound shown in formula II of purifying to obtain;
Described solvent is dimethyl sulfoxide (DMSO), dimethyl formamide, acetic acid or acetonitrile;
Described in described sodium acetate and claim 1, the mol ratio of benzoquinone compound is 1 ~ 10:1.
The application of the benzoquinone compound of 11. formula II chemical structures in preparing atovaquone.
12. application according to claim 11, it is characterized in that: under the condition existing at alkali, using alcohol as solvent, the benzoquinone compound generation back flow reaction of formula II chemical structure, after having reacted, washing, can obtain 3-hydroxyl-2-(4-(4-chloro-phenyl-) cyclohexyl)-1,4-naphthoquinone;
Shown in described alkali and formula II, the mol ratio of compound is 1 ~ 20:1.
13. application according to claim 12, is characterized in that:
Described alkali is sodium hydroxide, potassium hydroxide, hydrated barta, lithium hydroxide, carbonate or supercarbonate;
Described alcohol is one or more the mixture in methyl alcohol, ethanol, n-propyl alcohol, Virahol, propyl carbinol or isopropylcarbinol.
CN201310366156.7A 2013-08-21 2013-08-21 A kind of 2,3-bis-bromo-2,3-dihydro-1,4-naphthoquinone compounds, its preparation method and application thereof Active CN103570520B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310366156.7A CN103570520B (en) 2013-08-21 2013-08-21 A kind of 2,3-bis-bromo-2,3-dihydro-1,4-naphthoquinone compounds, its preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310366156.7A CN103570520B (en) 2013-08-21 2013-08-21 A kind of 2,3-bis-bromo-2,3-dihydro-1,4-naphthoquinone compounds, its preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN103570520A true CN103570520A (en) 2014-02-12
CN103570520B CN103570520B (en) 2016-08-31

Family

ID=50043319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310366156.7A Active CN103570520B (en) 2013-08-21 2013-08-21 A kind of 2,3-bis-bromo-2,3-dihydro-1,4-naphthoquinone compounds, its preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN103570520B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109876849A (en) * 2017-12-06 2019-06-14 中国科学院大连化学物理研究所 A kind of naphthalene liquid phase oxidation preparation 1,4- naphthoquinones catalyst and its preparation method and application
CN110734368A (en) * 2018-07-19 2020-01-31 新发药业有限公司 Preparation method of buparvaquone

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009007991A2 (en) * 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
WO2012153162A1 (en) * 2011-05-12 2012-11-15 Lupin Limited Novel method for preparation of atovaquone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009007991A2 (en) * 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
WO2012153162A1 (en) * 2011-05-12 2012-11-15 Lupin Limited Novel method for preparation of atovaquone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
丘坤元: "消除反应", 《化学通报》 *
丘坤元: "消除反应", 《化学通报》, no. 12, 31 December 1963 (1963-12-31), pages 51 - 58 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109876849A (en) * 2017-12-06 2019-06-14 中国科学院大连化学物理研究所 A kind of naphthalene liquid phase oxidation preparation 1,4- naphthoquinones catalyst and its preparation method and application
CN109876849B (en) * 2017-12-06 2020-08-11 中国科学院大连化学物理研究所 1, 4-naphthoquinone catalyst prepared by liquid-phase oxidation of naphthalene and preparation method and application thereof
CN110734368A (en) * 2018-07-19 2020-01-31 新发药业有限公司 Preparation method of buparvaquone
CN110734368B (en) * 2018-07-19 2022-08-12 新发药业有限公司 Preparation method of buparvaquone

Also Published As

Publication number Publication date
CN103570520B (en) 2016-08-31

Similar Documents

Publication Publication Date Title
CN109879843B (en) Barosavir intermediate, preparation method and application thereof
CN105330568B (en) Preparation method for p-aminobenzamidine hydrochloride
CN103613498B (en) The synthetic method of Win-35833
CN103570521A (en) Preparation method of atovaquone
CN103570520A (en) Benzoquinones compound, preparation method and application thereof
CN103833820A (en) Synthetic method of 3- succinic acid-30-stearyl alcohol glycyrrhetinate
CN101353296B (en) Method for preparing (Z)-3'-hydroxy-3,4,4',5-tetramethoxy diphenyl ethylene from regenerative natural plant resource
CN107216298A (en) A kind of preparation method of butylphenyl phthaleine
CN106279097A (en) A kind of preparation method of acrylic 1,3 sultones
CN106748716B (en) A kind of new method for preparing 2,4,5 trifluoro benzene acetic acids
CN106928047B (en) Synthesis method of hypolipidemic ciprofibrate
CN112010793B (en) Synthetic method of 2-methylsulfonyl-4-trifluoromethylbenzoic acid
CN104529726B (en) A kind of preparation method of o-hydroxyacetophenone
CN102690211B (en) The preparation method of tolvaptan intermediate
CN113861034A (en) Preparation method of 2-fluoro-3-nitrobenzoic acid
CN114315575A (en) Preparation method and application of photoinitiator intermediate
CN104876806A (en) Novel method for synthesizing bisoprolol importance intermediate
CN1800131B (en) 2,3,4,5-tetramethoxyl toluene synthesis method
CN111018928A (en) Synthetic method and application of gastrodin hemihydrate
CN109970529A (en) A kind of preparation method of 3- cyclopropyl rings butanone
CN103435450B (en) A kind of synthetic method of the TMHQ of environmental protection
CN101723841A (en) Preparation method of 2-amino-5-alkoxy propiophenone
CN104447252A (en) Method for preparing 6-methoxyl-2-naphthaldehyde
CN110615734A (en) Industrialized synthesis method of o-aldehyde phenyl fatty acid
RU2494087C1 (en) Method of producing omega-iodo-aliphatic carboxylic acids and esters thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: 273517 No. 50, Hualu Road, Zoucheng Industrial Park, Zoucheng City, Jining City, Shandong Province

Patentee after: SHANDONG LUKANG SHELILE PHARMACEUTICAL Co.,Ltd.

Address before: 272021 No. 173, Taibai West Road, Rencheng District, Jining City, Shandong Province

Patentee before: SHANDONG LUKANG SHELILE PHARMACEUTICAL Co.,Ltd.

CP02 Change in the address of a patent holder